logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jun Zhao

Department of Thoracic Oncology

44H指数
475论文数
1.1W被引数
收录论文 110
发表时间
logo
Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP)具有可操作基因组改变的非小细胞肺癌二线/三线治疗模式与疗效（RECAP）
errCLINICAL & EXPERIMENTAL METASTASIS
IF3.2
err2026-07-30
err0
errOAAI
errHanxiao Chen; Xiangjiao Meng; Ling Cai; Wei Lei; Yu Tang; Xi Shi; Leilei Ma; Jun Zhao
err分享
err收藏
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)奥希替尼联合或不联合萨沃利替尼治疗MET异常、EGFR突变非小细胞肺癌的一线治疗：随机II期试验（FLOWERS）
errNature Communications
IF15.7
err2026-01-13
err0
errOAAI
errAnna Li; Wei-Neng Feng; Juan Li; Bing-Fei Xu; Jun Zhao; Yun Jia; Ke-Jing Tang; Yong-Sheng Li; Cheng-Zhi Zhou; Yun Fan; Chong-Rui Xu; Yue-Li Sun; Hua-Jun Chen; Hong-Hong Yan; Zong-Kun Shi; Jin-Ji Yang
err分享
err收藏
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 studyVebreltinib治疗MET扩增驱动型晚期非小细胞肺癌（KUNPENG研究）：一项单臂、多队列、多中心、Ⅱ期研究
errThe Lancet Oncology
IF0
err2025-12-06
err0
PREAI
errYi-Long Wu; Yu Yao; Jin-Ji Yang; Lin Wu; Wei Zhang; Ying Wang; Hai-Peng Xu; Yong Song; Yan Zhang; Jun Zhao; Jing-Hua Chen; Zhe-Hai Wang; Qi-Ming Wang; Jie Hu; Xing-Ya Li; Yun Fan; Yuan Chen; Jian Fang; Di Han; Wei-Zhe Xue
err分享
err收藏
A novel nomogram based on DLL3 and PD-L1 for predicting the prognosis of patients with small cell lung cancer一种基于DLL3和PD-L1的新型列线图，用于预测小细胞肺癌患者的预后
errBMC Cancer
IF3.4
err2025-12-02
err0
errOAAI
errXiaoling Zhang; Weiling Li; Yunyi Du; Yuexiang Zhang; Ying Zhang; Rui Shi; Fei Su; Yan Zhang; Wenxuan Fan; Yu Wang; Yong’ai Li; Wenqing Hu; Jun Zhao
err分享
err收藏
17 β-Estradiol inhibits GSDME-mediated pyroptosis in ERα-positive breast cancer cells by promoting GSDME promoter methylation17β-雌二醇通过促进GSDME启动子甲基化抑制ERα阳性乳腺癌细胞中GSDME介导的焦亡
errJournal of Steroid Biochemistry and Molecular Biology
IF2.5
err2025-12-01
err0
PREAI
errPan, Yu; Li, Rui; Ma, Huanhuan; Hu, Xiaolei; Zhao, Jun; Qiao, Juanjuan; Dou, Xiyao; Wang, Yanan; Zhang, Yanzhi; Wang, Xiuli; Wang, Lin
err分享
err收藏
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies替利珠单抗联合西达维替尼或安洛替尼作为广泛期小细胞肺癌的维持治疗：两项前瞻性II期研究的结果
errINTERNATIONAL JOURNAL OF CANCER
IF4.7
err2025-11-01
err0
errOAAI
errYu, Sizhe; Li, Hui; Lu, Hongyang; Huang, Zhiyu; Chen, Kaiyan; Xu, Yanjun; Gong, Lei; Xie, Fajun; Qin, Jing; Yu, Xinmin; Zhao, Jun; Lou, Guangyuan; Wang, Wenxian; Gu, Cuiping; Han, Na; Xu, Xiaoling; Shao, Lan; Fan, Yun
err分享
err收藏
Hybrid nanovesicles enhance antitumor efficacy in KRAS-mutant non-small cell lung cancer杂交纳米囊泡可增强KRAS突变型非小细胞肺癌的抗肿瘤疗效
errJournal of Controlled Release
IF11.5
err2025-10-21
err0
PREAI
errHuan Yang; Lin Hu; Zhiyue Su; Fei Peng; Yuhong Wang; Chang Qi; Wenhao Shen; Kai Yang; Jun Zhao; Lingchuan Guo; Zhe Lei
err分享
err收藏
Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trialYK-029A在既往治疗过的EGFR T790M突变型NSCLC中的安全性与有效性：一项多中心I期临床试验
errLung Cancer
IF4.4
err2025-09-23
err0
errOAAI
errXinyu Wu; Rui Wan; Lin Wu; Mingfang Zhao; Yanqiu Zhao; Xiumei Dai; Jun Zhao; Zhe Liu; Yanyan Xie; Yueyin Pan; Zhihong Zhang; Yu Yao; Kunyu Yang; Bi Chen; Jie Wang; Jianchun Duan
err分享
err收藏
An Open-Label, Single-Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non-Small Cell Lung Cancer After First-Line PD-(L)1 Inhibitor一项开放标签、单臂、II期临床试验，评估Sintilimab联合Anlotinib治疗一线PD-(L)1抑制剂治疗后转移性非小细胞肺癌的疗效。
errCancer Medicine
IF3.1
err2025-09-04
err0
errOAAI
errXun Shi; Chen Lin; Lishu Lou; Qiong He; Guangyuan Lou; Wei Hong; Lan Shao; Jun Zhao; Cuiping Gu; Xinmin Yu; Ying Jin
err分享
err收藏
A prospective non-randomized interventional study of dynamic changes of L3SMI in patients with gastric cancer undergoing ambulatory chemotherapy with active nutrition combined with exercise一项前瞻性非随机化干预研究，探讨接受活动营养联合运动辅助的门诊化疗胃癌患者L3SMI的动态变化。
errFrontiers in Oncology
IF3.3
err2025-08-14
err0
errOAAI
errShu-Rong Zhao†; Xiao-Rong Li†; Zhen-Hao Li; Xiao-Juan Ren; Ji-Xiang Hou; Jun Zhao; Gao-Wa Jin; Quan-Fu Li
err分享
err收藏
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS StudyAmivantamab在晚期NSCLC和MET外显子14跳跃突变参与者中的应用: CHRYSALIS研究的最终结果
errJournal of Thoracic Oncology
IF20.8
err2025-05-16
err0
PREAI
errMatthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
err分享
err收藏
Prevalence, genetic variations and clinical outcomes of BRAF-V600 mutated advanced NSCLC in China: a retrospective real-world multi-centre study中国BRAF-V600突变晚期非小细胞肺癌的患病率、遗传变异和临床结局：一项回顾性真实世界多中心研究
errEBIOMEDICINE
IF10.8
err2025-04-01
err0
PREAI
errJia, Bo; Wang, Shuo; Zhang, Fengyuan; Wang, Ziping; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Li, Jianjie; Yang, Xue; Chen, Hanxiao; Chi, Yujia; Wang, Jingjing; Zhai, Xiaoyu; Nuersulitan, Reyizha; Wang, Xi; Tai, Yidi; Liu, Yiliang; Guan, Guohui; Zhao, Yanbin; Wang, Yudong; Zhang, Mengmeng; Liu, Xiuju; Liu, Lin; Li, Honglin; Wang, Yanlei; Shen, Fengqian; Liu, Zhiliang; Wang, Zhen; Man, Li; Zhang, Jiwei; Shi, Minmin; Li, Yong; Jiang, Caihong; Yan, Jingjing; Jin, Xin; Jin, Bo; Zhao, Jun
err分享
err收藏
Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study比较阿来替尼与克唑替尼序贯阿来替尼在ALK阳性晚期非小细胞肺癌患者中的真实世界疗效及ALEX研究中的疗效
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2025-04-01
err0
errOAAI
errYang, Xue; Liu, Yutao; Lin, Gen; Wang, Jinliang; Wang, Yudong; Zhang, Yan; Guo, Qinxiang; Liang, Fei; Zhao, Jun; Dong, Xiaorong
err分享
err收藏
Association between immune-related adverse events and prognosis in immune checkpoint inhibitor therapy: A bibliometric and visual analysis免疫相关不良事件与免疫检查点抑制剂治疗预后的关系：一项文献计量与可视化分析
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2025-03-18
err0
errOAAI
errJun Zhao; Xianghua Quan; Yu Liang; Beibei Ni; Xiaomin Xing; Guangwei Liu
err分享
err收藏
Adjuvant osimertinib in patients with completely resected, stage IB-IIIB NSCLC with uncommon EGFR mutations (ADMIN): Clinical characteristics, genomic profile and molecular residual diseaseADMIN研究中，在完全切除的IB-IIIB期NSCLC且携带少见EGFR突变的患者中应用辅助奥希替尼治疗：临床特征、基因组特征及分子残留病灶
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errLiu, C.; Han, Y.; Leng, X.; Yue, D.; Zhao, G.; Cheng, C.; Li, G.; Liang, N.; Zhao, J.; Liu, S.; Huang, W.; Wang, J.; Liu, L.
err分享
err收藏
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
errLANCET RESPIRATORY MEDICINE
IF32.8
err2024-10-01
err0
PREAI
errHan, Baohui; Feinstein, Trevor; Shi, Yuankai; Chen, Gongyan; Yao, Yu; Hu, Chunhong; Shi, Jianhua; Feng, Jifeng; Wu, Huijuan; Cheng, Ying; Guo, Qi-sen; Jie, Zhijun; Ye, Feng; Zhang, Yiping; Liu, Zhihua; Mao, Weidong; Zhang, Liangming; Lu, Junguo; Zhao, Jun; Bazhenova, Lyudmila; Ruiz, Jimmy; Kloecker, Goetz H.; Sujith, Kalmadi R.; Oliff, Ira A.; Wong, Matthew; Liu, Bin; Wu, Yanping; Huang, Lan; Sun, Yan
err分享
err收藏
Extracellular volume fraction can predict the treatment response and survival outcome of colorectal cancer liver metastases
errEUROPEAN JOURNAL OF RADIOLOGY
IF3.3
err2024-06-01
err1
PREAI
errLi, Shenglin; Yang, Xinmei; Lu, Ting; Yuan, Long; Zhang, Yuting; Zhao, Jun; Deng, Juan; Xue, Caiqiang; Sun, Qiu; Liu, Xianwang; Zhang, Wenjuan; Zhou, Junlin
err分享
err收藏
Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer
errONCOGENE
IF7.3
err2024-05-20
err10
errOAAI
errZhao, Jun; Shen, Jijie; Mao, Liang; Yang, Tianli; Liu, Jingyu; Hongbin, Sun
err分享
err收藏
Efficacy of YK-029A, a novel EGFR TKI, in advanced NSCLC patients with acquired T790M mutation
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errWan, Rui; Chau, Yi Fung; Zhao, Jun; Liu, Zhe; Zhao, Mingfang; Zhao, Yanqiu; Dai, Xiumei; Pan, Yueyin; Zhang, Zhihong; Yao, Yu; Yang, Kunyu; Wu, Lin; Xie, Yanyan; Chen, Bi; Yang, Yixuan; Guo, Yongqi; Wang, Jie; Duan, Jianchun
err分享
err收藏
A phase 1 study of D3S-001, a second-generation GDP-bound KRAS G12C inhibitor, as monotherapy in patients with KRAS G12C-mutated solid tumors
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errCho, Byoung Chul; Lu, Shun; Lee, Myung Ah; Song, Zhengbo; Park, John; Lim, Sun Min; Li, Ziming; Zhao, Jun; Richardson, Gary; Zhang, Yanqiao; Zhang, Jun; Liu, Anwen; Chen, Cheng; Wang, Jia; Lu, Jingtao; Rui, Haopeng; Chen, Qian; Wang, Hui; Zhang, Jing; Chen, Zhi Jian; Mok, Tony
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
张
张萍 (Ping Zhang)
H 指数: 136 · 论文数: 6.0K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
L
Luis Paz‐Ares
H 指数: 116 · 论文数: 1.4K
查看更多